Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results
Embecta (Nasdaq: EMBC) reported second quarter fiscal 2026 financial results and announced an analyst and investor conference call and live webcast on May 5, 2026 at 8:00 a.m. ET.
Rhea-AI Summary
Embecta (Nasdaq: EMBC) reported second quarter fiscal 2026 financial results and announced an analyst and investor conference call and live webcast on May 5, 2026 at 8:00 a.m. ET. A webcast replay will be available beginning at 11:00 a.m. ET on May 5, 2026 and archived for one year on the investor website.
Investors are directed to the company investor relations site for the full earnings press release and presentation.
Positive
- None.
Negative
- None.
Details
News Market Reaction – EMBC
In the May 5 session, EMBC declined 57.84%, reflecting a significant negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Earnings call time
- 8:00 a.m. ET
- Q2 FY2026 conference call start time on May 5, 2026
- Replay start time
- 11:00 a.m. ET
- Webcast replay availability on May 5, 2026
- Replay duration
- 1 year
- Earnings call replay archived on investor relations website
- Pre-earnings price
- $9.25
- Price before Q2 FY2026 results, near 52-week low
- 52-week high
- $15.55
- Upper end of EMBC’s 52-week trading range
- 52-week low
- $8.47
- Lower end of EMBC’s 52-week trading range
- Relative volume
- 1.61
- Today’s volume vs. 20-day average ahead of Q2 FY2026 earnings
- Short interest
- 9.96%
- Short interest as a percent of float, with 8.41 days to cover
Previous Earnings Reports
-
Reported Q1 FY2026 results and hosted earnings call and webcast.
-
Reported Q4 and FY2025 results with revenue declines and issued FY2026 guidance.
-
Strong Q3 FY2025 growth, higher EPS, debt reduction and guidance raise.
-
Q2 FY2025 revenues declined while margins improved and dividend maintained.
-
Q1 FY2025 results with revenue decline but slightly higher adjusted EPS and solid liquidity.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported second quarter fiscal 2026 financial results.
Visit the company’s Investor Relations website at http://investors.embecta.com to view the detailed second quarter fiscal 2026 earnings press release and investor presentation.
The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, May 5, 2026, which is accessible here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on May 5, 2026, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.